Company No: 07119954 (England and Wales)

Contents

• Balance Sheet
• Notes to the Financial Statements

		2025		2024
		£		£
Fixed assets		731		446
Current assets		67,288		91,591
Prepayments and accrued income		212		297
Creditors: amounts falling due within one year		( 152)		( 3,542)
Net current assets		67,348		88,346
Total assets less current liabilities		68,079		88,792
Accruals and deferred income		( 2,131)		( 2,184)
Net assets		65,948		86,608
Capital and reserves		65,948		86,608

For the financial year ending 31 January 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
• These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
• These financial statements have been delivered in accordance with the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Modus Medica Ltd (registered number: 07119954) were approved and authorised for issue by the Board of Directors and were signed on its behalf by:

Professor P M Hawkey Director

19 September 2025

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 07119954). The address of its registered office is Lower Bodham Farm House Church Road, Bodham, Holt, NR25 6PS, United Kingdom.

2. Employees

	2025		2024
	Number		Number
Monthly average number of persons employed by the Company during the financial year, including directors	2		2

3. Directors’ benefits: advances, credit and guarantees

Advances

During the period, the company made a short-term loan to the directors amounting to £4,581. This was cleared within 9 months after the year end.